Download presentation
Presentation is loading. Please wait.
1
Sepsis VTE Collaborative
Learning Session 3 Kevin Rooney, National Clinical Lead for Sepsis and Rhiann Oliver
6
A story of missed opportunities
7
60 year old male Admitted with a fall Died 22 hours later
6 missed opportunities NHS Greater Glasgow & Clyde conducted a SAER after 2 separate people report concerns. We are very grateful to the Board for sharing their learning. A 60 year old man is admitted to E.D. after a fall at home. He died in the admissions unit about 22 hours after admission. During his care there were 6 missed opportunities to treat the sepsis that led to his death.
8
Opportunity 1 – on admission
EWS 4 – no sepsis screen No IV cannula Prescribed antibiotics IV/oral Antibiotics given orally after 3 hours
9
Opportunity 2 – 2 hrs post admission
Seen on assessment unit by junior doctor Plan for urgent antibiotics, oxygen and urine sample No lactate sample Oxygen starts 4.5 hrs after admission IV Antibiotics 6 hours after admission No medical reassessment or senior review
10
Opportunity 3 – overnight
EWS 7 – no increased monitoring or escalation 9 hours post admission, noted as sweating ++ Temp 35.8° - no EWS scoring done 13 hours post admission – EWS 6. Escalated to junior doctor. Has not passed urine since admission
11
Opportunity 4 – morning medical review
Ordered fluid challenge, no lactate, no documentation of findings
12
Opportunity 5 – ward round
Nurse documents concern EWS 5 1 hour later EWS 7 – SCN alerted and is concerned Consultant ward round continuing in bed order – previous system to prioritise sick patients abandoned
13
Opportunity 6 – seen by Consultant
Diagnosis of sepsis & plan to treat Handed to junior doctor who is also asked to continue with ward round Junior doctor hands on plan to colleague Ward round leaves to see boarders No beds in HDU Seen by HDU doctor by chance 1 hour later who initiated consultant plan. Lactate 5.6 Suffers cardiac arrest & dies prior to HDU transfer
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.